×

Type to Explore

In Vitro Fertilization Market Size, Share & Outlook Growth
Home / Report Store / Health Sciences and Bio Innovation / In Vitro Fertilization Market Research Report 2024

In Vitro Fertilization Market Research Report 2024

In Vitro Fertilization Market Global Industry Analysis And Forecast (2024-2032) By Product Type (Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Ovum Aspiration Pump, And Sperm Separation Devices, Micromanipulator, Others{ Laser systems, Gas Analyzers, Anti-Vibration Tables}), Type (Conventional IVF, IVF with ICSI, IVF with Donor Eggs, Others {Traditional IVF}) Cycle (Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycles), End-User (Fertility clinics, Hospitals & Surgical Centers, Cryobanks, Research Institutes), And Region

Published date: Mar 2025 Report ID: 235 Number of Pages: 250
Format:

In Vitro Fertilization Market Synopsis

In Vitro Fertilization Market Size Was Valued at USD 759.40 Million in 2023 and is Projected to Reach USD 1718.69 Million by 2032, Growing at a CAGR of 9.5% From 2024-2032.

In Vitro Fertilization is a process of Fertilization in which eggs are removed from a woman’s ovary and combined with sperm outside the body in vitro conditions to form embryos. The embryos are grown in the laboratory for several days and then either placed in a woman’s uterus or cryopreserved for future use also called IVF.The IVF technique can be more beneficial in Overcoming infertility, for couples who have difficulty conceiving naturally due to factors like blocked fallopian tubes, low sperm count, or any other ovulation disorders.

It is also applicable in Genetic screening to screen embryos for genetic disorders, this helps in the selection of healthy embryos for transfer and reduces the risk of passing on genetic conditions It also allows individuals to preserve their fertility by cryopreservation technique for freezing embryos, eggs, or sperm for future use, which is particularly helpful for individuals who are undergoing treatments like chemotherapy which may affect their fertility. It also enables same-gender couples and single individuals to have biological children. It is used in gestational surrogacy, which allows individuals to carry a pregnancy and have a biological child for those who have no child. It has also contributed to advancements in reproductive research, like studying early embryonic development and improving assisted reproductive technologies.

Top Active Players Involved are:

“TFP Fertility, Vitrolife AB, Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA (EMD Serono), Ferring Pharmaceuticals, Esco Micro Pte Ltd, Boston IVF, IVFtech ApS, Rocket Medical plc, IVI Fertility, THE COOPER COMPANIES, INC, COOK GROUP, VITROLIFE, Servy Massey Fertility Institute, Houston Fertility Center, Conceptions Reproductive Associates of Colorado, New Hope Fertility Center, Sher Institute for Reproductive Medicine (Sirm), Cardone Reproductive Medicine and Infertility, Fertility Center of San Antoni, Reproductive Medicine Associate, Fertility And Gynecology Center Monterey Bay Ivf, Nikon Corporation, Cooper Companies Inc. and Other Active Players.”

In Vitro Fertilization Market Segment Analysis:

In Vitro Fertilization Market Segmented on the basis of Product Type, Type, Cycle, End-User, Segment5, And Segment6.

By Cycle, Fresh-Non-Donor Segment Is Expected to Dominate the Market During the Forecast Period

  • Fresh non-donor cycles often have higher success rates when compared to other segments. As in the IVF process, Fresh eggs and sperm have a better chance of resulting in successful fertilization and implantation.
  • They are considered the best choice for Personalized treatment, where the individual's eggs and sperm allow for a closer genetic match, potentially increasing the chances of successful fertilization and implantation.
  • The availability of fresh eggs and sperm from the intended parents is relatively easier to manage compared to acquiring donor gametes. This cycle is more convenient and accessible.
  • They are often more cost-effective when compared to other options, like using donor eggs or frozen embryos. In this way, fresh non-donor cycles are a preferred choice for many individuals, and couples who are looking for IVF Treatment.

By End-User, Fertility Clinics Segment Held the Largest Share In 2023

  • Fertility clinics are dedicated to healthcare facilities that are equipped with specialized infrastructure, laboratories, and advanced reproductive technologies that offer fertility treatments, including IVF, making them a primary choice for individuals and couples who are looking for reproductive services.
  • They are staffed with highly skilled fertility specialists, reproductive endocrinologists, embryologists, and other healthcare professionals who have extensive experience in diagnosing and managing fertility-related issues.
  • They provide a wide range of services related to fertility evaluation, ovulation induction, diagnostic testing, egg retrieval, embryo transfer, and post-treatment monitoring.
  • They often engage in research and clinical trials, where these advancements include techniques like intracytoplasmic sperm injection, preimplantation genetic testing, time-lapse embryo monitoring, and many other techniques.
  • They also collaborate with reproductive endocrinology specialists, urologists, gynecologists, and other healthcare providers to treat the patients properly by taking care, of them without any issues. Hence, In this way, Fertility Clinics are dominant and play a major role in IVF.

  • The global fertility services market was valued at 20 billion U.S. dollars in 2018, this value was 32 billion U.S. dollars in 2023, increased by 12 billion U.S. dollars. Women choosing to have children at a later age is said to be a large factor behind the growth of this market as more people will require fertility services.

In Vitro Fertilization Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast Period

  • The Asia Pacific region has a huge population, and also fertility issues are prevalent in the region. Factors like changing lifestyles, delayed pregnancies, and increasing awareness of fertility treatments have contributed to a rise in demand for Invitro Fertilization services.
  • It has embraced technological advancements in the field of IVF, including improved laboratory techniques, genetic testing, embryo selection methods, and many others, these advancements have led to an increase in the success rate in pregnancy of women.
  • Rising disposable incomes have made IVF treatments more accessible to a larger population and also countries like China, Japan, and India have medical tourism, which is attracting patients from other countries due to the availability of high-quality, and Low-cost treatments compared to other countries.
  • The government policies and initiatives to support assisted reproductive technologies in this region are also helping the people through funding in many ways. Hence, in this way, this region is dominated by IVF treatments.

In Vitro Fertilization Market Active Players

  • Tfp Fertility (UK)
  • Vitrolife Ab (Sweden)
  • Irvine Scientific (USA)
  • Thermo Fisher Scientific Inc. (USA)
  • Merck Kgaa (Emd Serono) (Germany)
  • Ferring Pharmaceuticals (Switzerland)
  • Esco Micro Pte Ltd (Singapore)
  • Boston Ivf (USA)
  • Ivftech Aps (Denmark)
  • Rocket Medical Plc (USA)
  • Ivi Fertility (Spain)
  • The Cooper Companies, Inc. (USA)
  • Cook Group (USA)
  • Vitrolife (Sweden)
  • Servy Massey Fertility Institute (USA)
  • Houston Fertility Center (USA)
  • Conceptions Reproductive Associates of Colorado (USA)
  • New Hope Fertility Center (USA)
  • Sher Institute for Reproductive Medicine (Sirm) (USA)
  • Cardone Reproductive Medicine and Infertility (USA)
  • Fertility Center of San Antoni (USA)
  • Reproductive Medicine Associate (USA)
  • Fertility And Gynecology Center Monterey Bay Ivf (USA)
  • Nikon Corporation (Japan)
  • Cooper Companies Inc. (USA)And Other Active Players.

Key Industry Developments in the In Vitro Fertilization Market:

  • In April 2024, Gameto a female-led biotechnology company with a mission to redefine women's healthcare, Announced New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solutions for Fertility Care, this process by which a therapy developed from induced pluripotent stem cells (iPSC) has the potential to enhance in vitro fertilization.
  • In March 2024, Alife Health a leading fertility technology company specializing in the development of AI tools for in vitro fertilization announced a groundbreaking partnership with Boston IVF, a leading fertility clinic to pilot the country's first AI tool for IVF medication optimization which is designed to help IVF clinicians to retrieve the optimal number of eggs for each patient and reduce overall medication costs.

In Vitro Fertilization Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 759.40 Mn.

Forecast Period 2024-32 CAGR:

9.5 %

Market Size in 2032:

USD 1718.69 Mn.

Segments Covered:

By Product Type

  • Imaging Systems
  • Incubators
  • Cryosystems
  • IVF Cabinet
  • Ovum Aspiration Pump
  • Sperm Separation Devices
  • Micromanipulator
  • Others {Laser systems, Gas Analyzers, Anti-Vibration Tables}

By Type

  • Conventional IVF
  • IVF with ICSI
  • IVF with Donor Eggs
  • Others {Traditional IVF}

By Cycle

  • Fresh Non-donor IVF Cycles
  • Frozen Non-donor IVF Cycles
  • Frozen Donor IVF Cycles
  • Fresh Donor IVF Cycles

By End-User

  • Fertility clinics
  • Hospitals & Surgical Centers
  • Cryobanks
  • Research Institutes

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Delayed Onset of Pregnancy

Key Market Restraints:

  • High Cost of IVF method

Key Opportunities:

  • Increase Launches of IVF Facilities and New Technologies

Companies Covered in the report:

  • TFP Fertility, Vitrolife AB, Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA (EMD Serono), Ferring Pharmaceuticals, Esco Micro Pte Ltd, and Other Active Players.

Chapter 1: Introduction

 1.1 Scope and Coverage



Chapter 2:Executive Summary



Chapter 3: Market Landscape

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Challenges

 3.2 Market Trend Analysis

 3.3 PESTLE Analysis

 3.4 Porter's Five Forces Analysis

 3.5 Industry Value Chain Analysis

 3.6 Ecosystem

 3.7 Regulatory Landscape

 3.8 Price Trend Analysis

 3.9 Patent Analysis

 3.10 Technology Evolution

 3.11 Investment Pockets

 3.12 Import-Export Analysis



Chapter 4: In Vitro Fertilization Market by By Product Type

 4.1 In Vitro Fertilization Market Snapshot and Growth Engine

 4.2 In Vitro Fertilization Market Overview

 4.3 Imaging Systems

  4.3.1 Introduction and Market Overview

  4.3.2 Historic and Forecasted

Frequently Asked Questions

What would be the forecast period in the In Vitro Fertilization Market research report?

The forecast period in the In Vitro Fertilization Market research report is 2024-2032.

Who are the key players in the In Vitro Fertilization Market?

TFP Fertility, Vitrolife AB, Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA (EMD Serono), Ferring Pharmaceuticals, Esco Micro Pte Ltd, Boston IVF, IVFtech ApS, Rocket Medical plc, IVI Fertility, THE COOPER COMPANIES, INC, COOK GROUP, VITROLIFE, Servy Massey Fertility Institute, Houston Fertility Center, Conceptions Reproductive Associates of Colorado, New Hope Fertility Center, Sher Institute for Reproductive Medicine (Sirm), Cardone Reproductive Medicine and Infertility, Fertility Center of San Antoni, Reproductive Medicine Associate, Fertility And Gynecology Center Monterey Bay Ivf, Nikon Corporation, Cooper Companies Inc. and Other Active Players.

What are the segments of the In Vitro Fertilization Market?

The In Vitro Fertilization Market is segmented into Product Type, Type, Cycle, End-User, Segment5, Segment6, and region. By Product Type, the market is categorized into Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Ovum Aspiration Pump, Sperm Separation Devices, Micromanipulators, Other {Laser systems, Gas Analyzers, Anti-Vibration Tables}. By Type, the market is categorized into Conventional IVF, IVF with ICSI, IVF with Donor Eggs, and Others {Traditional IVF}. By Cycle, the market is categorized into Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, and Fresh Donor IVF Cycles. By End-User, the market is categorized into Fertility clinics, Hospitals & Surgical Centers, Cryobanks, and Research Institutes. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the In Vitro Fertilization Market?

In Vitro Fertilization is a process of Fertilization in which eggs are removed from a woman’s ovary and combined with sperm outside the body in vitro conditions to form embryos.

How big is the In Vitro Fertilization Market?

In Vitro Fertilization Market Size Was Valued at USD 759.40 Million in 2023 and is Projected to Reach USD 1718.69 Million by 2032, Growing at a CAGR of 9.5% From 2024-2032.

Purchase Benefits
  • Eligible for a free updated report
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours

Report ID: 235

Published Date: 2025-03-11

Number of Pages: 250

Speak To Analyst

Akshay Patil